1. Home
  2. HTCR vs CLRB Comparison

HTCR vs CLRB Comparison

Compare HTCR & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

N/A

Current Price

$0.25

Market Cap

6.5M

Sector

Technology

ML Signal

N/A

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

N/A

Current Price

$2.96

Market Cap

12.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HTCR
CLRB
Founded
2009
2002
Country
Japan
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
12.9M
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
HTCR
CLRB
Price
$0.25
$2.96
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
362.4K
36.8K
Earning Date
05-22-2026
01-01-0001
Dividend Yield
51.18%
N/A
EPS Growth
66.67
N/A
EPS
N/A
N/A
Revenue
$30,407,229.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
39.19
N/A
52 Week Low
$0.22
$0.23
52 Week High
$1.66
$10.19

Technical Indicators

Market Signals
Indicator
HTCR
CLRB
Relative Strength Index (RSI) 45.11 45.76
Support Level $0.25 $2.61
Resistance Level $0.30 $3.60
Average True Range (ATR) 0.03 0.26
MACD 0.00 -0.02
Stochastic Oscillator 31.30 31.03

Price Performance

Historical Comparison
HTCR
CLRB

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: